Neumora Therapeutics, Inc. (NMRA)
0.3339
-0.01
(-3.78%)
USD |
NASDAQ |
Nov 20, 16:00
0.3387
0.00 (0.00%)
After-Hours: 20:00
Neumora Therapeutics Total Return Level : 0.3339 for Nov. 20, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 20, 2026 | 0.3339 |
| November 19, 2026 | 0.347 |
| November 18, 2026 | 0.3668 |
| November 17, 2026 | 0.3345 |
| November 16, 2026 | 0.3695 |
| November 13, 2026 | 0.4289 |
| November 12, 2026 | 0.433 |
| November 11, 2026 | 0.473 |
| November 10, 2026 | 0.4666 |
| November 09, 2026 | 0.4859 |
| November 06, 2026 | 0.5033 |
| November 05, 2026 | 0.487 |
| November 04, 2026 | 0.566 |
| November 03, 2026 | 0.5709 |
| November 02, 2026 | 0.4957 |
| October 30, 2026 | 0.3672 |
| October 29, 2026 | 0.3883 |
| October 28, 2026 | 0.3931 |
| October 27, 2026 | 0.3681 |
| October 26, 2026 | 0.3929 |
| October 23, 2026 | 0.3794 |
| October 22, 2026 | 0.4057 |
| October 21, 2026 | 0.416 |
| October 20, 2026 | 0.465 |
| October 19, 2026 | 0.47 |
| Date | Value |
|---|---|
| October 16, 2026 | 0.4738 |
| October 15, 2026 | 0.427 |
| October 14, 2026 | 0.3545 |
| October 13, 2026 | 0.3702 |
| October 12, 2026 | 0.4373 |
| October 09, 2026 | 0.4757 |
| October 08, 2026 | 0.4798 |
| October 07, 2026 | 0.4683 |
| October 06, 2026 | 0.471 |
| October 05, 2026 | 0.5253 |
| October 02, 2026 | 0.4999 |
| October 01, 2026 | 0.55 |
| September 30, 2026 | 0.5962 |
| September 29, 2026 | 0.6776 |
| September 28, 2026 | 0.6918 |
| September 25, 2026 | 0.6776 |
| September 24, 2026 | 0.7031 |
| September 23, 2026 | 0.7313 |
| September 22, 2026 | 0.7785 |
| September 21, 2026 | 0.6918 |
| September 18, 2026 | 0.73 |
| September 17, 2026 | 0.75 |
| September 16, 2026 | 0.7732 |
| September 15, 2026 | 0.8313 |
| September 14, 2026 | 0.9994 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| EyePoint, Inc. | 0.2342 |
| Context Therapeutics, Inc. | 0.16 |
| LENZ Therapeutics, Inc. | 3.154 |
| ANI Pharmaceuticals, Inc. | 68.55 |
| Corcept Therapeutics, Inc. | 63.62 |